|
Volumn 7, Issue 4, 1995, Pages 280-283
|
The Defined Daily Dose as a Tool in Pharmacoeconomics: Advantages and Limitations
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CARDIAC GLYCOSIDE;
CARDIOVASCULAR AGENT;
DIURETIC AGENT;
NITRIC ACID DERIVATIVE;
VASODILATOR AGENT;
VERAPAMIL;
ANALYTIC METHOD;
CARDIOVASCULAR DISEASE;
DRUG DOSE;
DRUG USE;
ECONOMICS;
HUMAN;
METHODOLOGY;
PHARMACOECONOMICS;
PRIORITY JOURNAL;
SHORT SURVEY;
COST-BENEFIT ANALYSIS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY;
ECONOMICS, PHARMACEUTICAL;
HEALTH CARE COSTS;
HUMAN;
|
EID: 0028955392
PISSN: 11707690
EISSN: 11792027
Source Type: Journal
DOI: 10.2165/00019053-199507040-00002 Document Type: Article |
Times cited : (30)
|
References (23)
|